Clinical Report: Association of Hemoglobin Glycation Index with Risk of MCI

Overview

This study investigates the relationship between hemoglobin glycation index (HGI) and the risk of mild cognitive impairment (MCI) in older adults. Findings indicate that both low and high HGI values are associated with an increased risk of MCI.

Background

Mild cognitive impairment (MCI) is a critical transitional stage between normal aging and dementia, with a significant prevalence among the elderly. Identifying risk factors for MCI is essential for early intervention. The hemoglobin glycation index (HGI) offers a novel approach to assess individual variations in hemoglobin glycation susceptibility, which may correlate with cognitive decline.

Data Highlights

Key Findings

• 19.01% of participants in the study had mild cognitive impairment (MCI).
• A significant U-shaped relationship was found between HGI and MCI risk (p < 0.05).
• Both low (Q1) and high (Q5) HGI values were associated with a higher risk of MCI compared to the middle quintile (Q2).
• The increased MCI risk associated with HGI was observed in subgroups including individuals under 65 years, males, non-diabetics, and those with cardiovascular diseases (all p < 0.05).
• The study utilized data from 5,723 participants aged 45 years and older from the CHARLS database.

Clinical Implications

The findings indicate that HGI is associated with the risk of MCI in older adults.

Conclusion

The study highlights the association of HGI with the risk of MCI among older adults.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. ADA’s Standards of Care in Diabetes—2026
6. https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-024-02206-1.pdf